2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 35121623 | Clinical Significance of PIK3CA and ESR1 Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant. | 2022 Apr 14 | 1 |
| 2 | 31464525 | Abemaciclib, a potent cyclin-dependent kinase 4 and 6 inhibitor, for treatment of ER-positive metastatic breast cancer. | 2019 Oct | 1 |